TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 36 filers reported holding TRACON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $579,000 | -16.5% | 346,719 | 0.0% | 0.03% | -19.4% |
| Q2 2022 | $693,000 | -24.0% | 346,719 | 0.0% | 0.04% | +38.5% |
| Q1 2022 | $912,000 | -5.0% | 346,719 | +0.0% | 0.03% | +36.8% |
| Q4 2021 | $960,000 | -28.5% | 346,718 | 0.0% | 0.02% | +18.8% |
| Q3 2021 | $1,342,000 | -40.4% | 346,718 | 0.0% | 0.02% | -44.8% |
| Q2 2021 | $2,250,000 | -92.1% | 346,718 | 0.0% | 0.03% | -95.5% |
| Q1 2021 | $28,535,000 | +603.4% | 346,718 | 0.0% | 0.64% | +498.1% |
| Q4 2020 | $4,057,000 | +126.3% | 346,718 | 0.0% | 0.11% | +40.8% |
| Q3 2020 | $1,793,000 | +163.7% | 346,718 | 0.0% | 0.08% | +181.5% |
| Q2 2020 | $680,000 | +15.4% | 346,718 | 0.0% | 0.03% | -12.9% |
| Q1 2020 | $589,000 | – | 346,718 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 4,125,322 | $8,251,000 | 3.72% |
| Ikarian Capital, LLC | 2,788,853 | $5,577,000 | 1.02% |
| Telemetry Investments, L.L.C. | 100,000 | $200,000 | 0.24% |
| ACT CAPITAL MANAGEMENT, LLC | 28,500 | $57,000 | 0.08% |
| JOHNSON & JOHNSON | 84,003 | $168,000 | 0.04% |
| NEA Management Company, LLC | 346,719 | $693,000 | 0.04% |
| X-Square Capital, LLC | 17,973 | $36,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 268,301 | $537,000 | 0.01% |
| LINDEN ADVISORS LP | 454,916 | $910,000 | 0.01% |
| DOWLING & YAHNKE LLC | 47,455 | $95,000 | 0.00% |